Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

First patient dosed in phase II psoriasis trial of ABY-035

March 22, 2018

FDA approves Ilumya for moderate to severe plaque psoriasis

March 21, 2018

SNA-125 begins proof-of-concept trial in atopic dermatitis

March 13, 2018

European Commission approves Ameluz with daylight PDT

March 7, 2018

Phase III trials of olumacostat glasaretil for acne do not meet co-primary endpoints

March 6, 2018

AEC syndrome pathology linked to protein aggregation of the p63 transcription factor

March 6, 2018

DCIR found as potential therapeutic target for atopic dermatitis

March 5, 2018

Merck KGaA divulges novel BTK inhibitors

March 5, 2018

Valeant enters licensing agreement with Kaken for KP-470-based products for psoriasis

March 1, 2018

Mirikizumab improves quality of life of patients with moderate to severe psoriasis

Feb. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...